Clinical Trials Directory

Trials / Completed

CompletedNCT06271486

Pregabalin in Treatment of Postdural Puncture Headache

Pregabalin as Alternative to Epidural Blood Patch in Treatment of Postdural Puncture Headache: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Lumbar puncture (LP), often known as a "spinal tap," is a standard medical technique pioneered in the late 1900s by Heinrich Quincke. It involves the retrieval and analysis of cerebrospinal fluid (CSF) from the spinal cord, serving as the benchmark for diagnosing conditions like subarachnoid hemorrhage, meningitis, and specific neurological conditions. Pregabalin, an anticonvulsant medicine that blocks calcium entry, is used to treat a variety of diseases. It has been used to relieve pain in a variety of patient groups, including those with chronic pain, epilepsy, and anxiety disorders

Conditions

Interventions

TypeNameDescription
DRUGPregabalin 75mgGroup A (pregabalin group) received oral pregabalin treatment administered at 150 mg daily, with 75 mg given every 12 hours.
BIOLOGICALAn epidural blood patch (EBP)Group B (EBP group) received active therapy in the form of an EBP
COMBINATION_PRODUCTconservative treatment.Group C (control group) received conservative treatment providing recommendations to the patients, including 24 hours of bed rest, stool softener, and consuming a minimum of 2.0 liters of fluid daily. Analgesics were permitted for pain relief depending on the patient's disease status.

Timeline

Start date
2024-02-28
Primary completion
2024-08-15
Completion
2024-08-15
First posted
2024-02-21
Last updated
2025-06-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06271486. Inclusion in this directory is not an endorsement.